Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September:

Metadata
Provider: 
Business Wire, Inc.
Retrieved on: 
Friday, August 30, 2019
Information
Tags: 
Biotechnology, Health, Genetics, Pharmaceutical, Branches of biology, Biology, Life sciences, Sangamo Therapeutics, Genetic engineering, Genome editing, Gene therapy
Geotags: 
United States, California
⚠ generated by AI ↴
Organisation: 
SANGAMO THERAPEUTICS
Summary
Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September:
    Presentation Date: Thursday, Sept 5th at 10:55 a.m. Eastern Time
    Presentation Date: Monday, Sept 9th at 8:10 a.m. Eastern Time
    Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations .
  • The presentation will also be available on the Sangamo website after the event.
  • Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation.
  • For more information about Sangamo, visit www.sangamo.com .


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September:

  • Wells Fargo 2019 Healthcare Conference

    Presentation Date: Thursday, Sept 5th at 10:55 a.m. Eastern Time

    Location: Boston, MA
  • Morgan Stanley 17th Annual Global Healthcare Conference

    Presentation Date: Monday, Sept 9th at 8:10 a.m. Eastern Time

    Location: New York, NY

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Copyright: 
Copyright Business Wire 2019